The adhesin complex protein (ACP) of Neisseria meningitidis is a new adhesin with vaccine potential

mBio

Volumn 4, Issue 2, 2013, Pages

  Hung, Miao Chiu ^a   Heckels, John E ^a   Christodoulides, Myron ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; INVASIN; LIPOSOME; MENINGOCOCCUS VACCINE; RECOMBINANT ADHESIN COMPLEX PROTEIN; SODIUM CHLORIDE; UNCLASSIFIED DRUG; RECOMBINANT VACCINE;

ACP GENE; AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ARTICLE; BACTERIAL COUNT; BACTERIAL GENE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BACTERIUM ADHERENCE; CONTROLLED STUDY; EPITHELIUM CELL; ESCHERICHIA COLI; GENE EXPRESSION; GENE SILENCING; GENETIC DATABASE; HUMAN; HUMAN CELL; IMMUNIZATION; IN VITRO STUDY; MICELLE; MOLECULAR CLONING; MOUSE; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PURIFICATION; RABBIT; SEQUENCE HOMOLOGY; WILD TYPE; ANIMAL; BAGG ALBINO MOUSE; CELL LINE; CHEMISTRY; GENETIC VARIABILITY; GENETICS; IMMUNOLOGY; MENINGOCOCCOSIS; MICROBIAL VIABILITY; MICROBIOLOGY; MOLECULAR WEIGHT; SERUM BACTERICIDAL ACTIVITY;

ADHESINS, BACTERIAL; ANIMALS; BACTERIAL ADHESION; BLOOD BACTERICIDAL ACTIVITY; CELL LINE; CLONING, MOLECULAR; EPITHELIAL CELLS; ESCHERICHIA COLI; GENE EXPRESSION; GENETIC VARIATION; HUMANS; MENINGOCOCCAL INFECTIONS; MENINGOCOCCAL VACCINES; MICE; MICE, INBRED BALB C; MICROBIAL VIABILITY; MOLECULAR WEIGHT; NEISSERIA MENINGITIDIS, SEROGROUP B; RABBITS; VACCINES, SYNTHETIC;

EID: 84880036688     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00041-13     Document Type: Article

References (30)

1. Snape MD, Perrett KP, Ford KJ, John TM, Pace D, Yu LM, Langley JM, McNeil S, Dull PM, Ceddia F, Anemona A, Halperin SA, Dobson S, Pollard AJ. 2008. Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trial. JAMA 299: 173-184.
2. Finne J, Leinonen M, Mäkelä PH. 1983. Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis. Lancet ii:355-357.
3. Holst J, Martin D, Arnold R, Huergo CC, Oster P, O'Hallahan J, Rosenqvist E. 2009. Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis. Vaccine 27(Suppl 2):B3-12.
4. Granoff DM. 2010. Review of meningococcal group B vaccines. Clin. Infect. Dis. 50(Suppl 2):S54-S65.
5. Palumbo E, Fiaschi L, Brunelli B, Marchi S, Savino S, Pizza M. 2012. Antigen identification starting from the genome: a "Reverse vaccinology" approach applied to MenB, p. 361-403. In ChristodoulidesM(ed.), Neisseria meningitidis: advanced methods and protocols. Humana Press, New York, NY.
6. Serruto D, Bottomley MJ, Ram S, Giuliani MM, Rappuoli R. 2012. The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: immunological, functional and structural characterization of the antigens. Vaccine 30(Suppl 2):B87-B97.
7. Bai X, Findlow J, Borrow R. 2011. Recombinant protein meningococcal serogroup B vaccine combined with outer membrane vesicles. Expert Opin. Biol. Ther. 11:969-985.
8. Nissen MD, Marshall HS, Richmond PC, Jiang Q, Harris SL, Jones TR, Jansen KU, Perez JL. 30 October 2012. A randomized, controlled, phase 1/2 trial of a Neisseria meningitidis serogroup B bivalent rLP2086 vaccine in healthy children and adolescents. Pediatr. Infect. Dis. J. (Epub ahead of print.)
9. Stephens DS. 2012. Prevention of serogroup B meningococcal disease. Lancet 379:592-594.
10. Tettelin H, Saunders NJ, Heidelberg J, Jeffries AC, Nelson KE, Eisen JA, Ketchum KA, Hood DW, Peden JF, Dodson RJ, Nelson WC, Gwinn ML, DeBoy R, Peterson JD, Hickey EK, Haft DH, Salzberg SL, White O, Fleischmann RD, Dougherty BA, Mason T, Ciecko A, Parksey DS, Blair E, Cittone H, Clark EB, Cotton MD, Utterback TR, Khouri H, Qin H, Vamathevan J, Gill J, Scarlato V, Masignani V, Pizza M, Grandi G, Sun L, Smith HO, Fraser CM, Moxon ER, Rappuoli R, Venter JC. 2000. Complete genome sequence of Neisseria meningitidis serogroup B strain MC58. Science 287:1809-1815.
11. Post DM, Zhang D, Eastvold JS, Teghanemt A, Gibson BW, Weiss JP. 2005. Biochemical and functional characterization of membrane blebs purified from Neisseria meningitidis serogroup B. J. Biol. Chem. 280: 38383-38394.
12. Ferrari G, Garaguso I, Adu-Bobie J, Doro F, Taddei AR, Biolchi A, Brunelli B, Giuliani MM, Pizza M, Norais N, Grandi G. 2006. Outer membrane vesicles from group B Neisseria meningitidis delta gna33 mutant: proteomic and immunological comparison with detergentderived outer membrane vesicles. Proteomics 6:1856-1866.
13. Grifantini R, Sebastian S, Frigimelica E, Draghi M, Bartolini E, Muzzi A, Rappuoli R, Grandi G, Genco CA. 2003. Identification of ironactivated and -repressed Fur-dependent genes by transcriptome analysis of Neisseria meningitidis group B. Proc. Natl. Acad. Sci. U. S. A. 100: 9542-9547.
14. Jolley KA, Maiden MC. 2010. BIGSdb: scalable analysis of bacterial genome variation at the population level. BMC Bioinformatics 11:595.
15. Virji M, Makepeace K, Peak IR, Ferguson DJ, Jennings MP, Moxon ER. 1995. Opc- and pilus-dependent interactions of meningococci with human endothelial cells: molecular mechanisms and modulation by surface polysaccharides. Mol. Microbiol. 18:741-754.
16. Virji M. 2009. Pathogenic neisseriae: surface modulation, pathogenesis and infection control. Nat. Rev. Microbiol. 7:274-286.
17. Hardy SJ, Christodoulides M, Weller RO, Heckels JE. 2000. Interactions of Neisseria meningitidis with cells of the human meninges. Mol. Microbiol. 36:817-829.
18. Hung MC, Salim O, Williams JN, Heckels JE, Christodoulides M. 2011. The Neisseria meningitidis macrophage infectivity potentiator protein induces cross-strain serum bactericidal activity and is a potential serogroup B vaccine candidate. Infect. Immun. 79:3784-3791.
19. Christodoulides M, Brooks JL, Rattue E, Heckels JE. 1998. Immunization with recombinant class 1 outer-membrane protein from Neisseria meningitidis: influence of liposomes and adjuvants on antibody avidity, recognition of native protein and the induction of a bactericidal immune response against meningococci. Microbiology 144(Pt 11):3027-3037.
20. Serruto D, Adu-Bobie J, Scarselli M, Veggi D, Pizza M, Rappuoli R, Aricò B. 2003. Neisseria meningitidis App, a new adhesin with autocatalytic serine protease activity. Mol. Microbiol. 48:323-334.
21. Capecchi B, Adu-Bobie J, Di Marcello F, Ciucchi L, Masignani V, Taddei A, Rappuoli R, Pizza M, Aricò B. 2005. Neisseria meningitidis NadA is a new invasin which promotes bacterial adhesion to and penetration into human epithelial cells. Mol. Microbiol. 55:687-698.
22. Scarselli M, Serruto D, Montanari P, Capecchi B, Adu-Bobie J, Veggi D, Rappuoli R, Pizza M, Aricò B. 2006. Neisseria meningitidis NhhA is a multifunctional trimeric autotransporter adhesin. Mol. Microbiol. 61: 631-644.
23. Comanducci M, Bambini S, Brunelli B, Adu-Bobie J, Aricò B, Capecchi B, Giuliani MM, Masignani V, Santini L, Savino S, Granoff DM, Caugant DA, Pizza M, Rappuoli R, Mora M. 2002. NadA, a novel vaccine candidate of Neisseria meningitidis. J. Exp. Med. 195:1445-1454.
24. McNeil G, Virji M. 1997. Phenotypic variants of meningococci and their potential in phagocytic interactions: the influence of opacity proteins, pili, PilC and surface sialic acids. Microb. Pathog. 22:295-304.
25. Zak K, Diaz JL, Jackson D, Heckels JE. 1984. Antigenic variation during infection with Neisseria gonorrhoeae: detection of antibodies to surface proteins in sera of patients with gonorrhea. J. Infect. Dis. 149:166-173.
26. Heckels JE. 1981. Structural comparison of Neisseria gonorrhoeae outer membrane proteins. J. Bacteriol. 145:736-742.
27. Schägger H. 2006. Tricine-SDS-PAGE. Nat. Protoc. 1:16-22.
28. Rusniok C, Vallenet D, Floquet S, Ewles H, Mouzé-Soulama C, Brown D, Lajus A, Buchrieser C, Médigue C, Glaser P, Pelicic V. 2009. NeMeSys: a biological resource for narrowing the gap between sequence and function in the human pathogen Neisseria meningitidis. Genome Biol. 10:R110.
29. van Dam V, Bos MP. 2012. Generating knockout and complementation strains of Neisseria meningitidis, p. 55-72. In Christodoulides M (ed.), Neisseria meningitidis: advanced methods and protocols. Humana Press, New York, NY.
30. Stohl EA, Seifert HS. 2001. The recX gene potentiates homologous recombination in Neisseria gonorrhoeae. Mol. Microbiol. 40:1301-1310.